Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis Of Cml Patients
Tarih
2013Yazar
Şahin, Fahri
Saydam, Güray
Cömert, Melda
Uz, Burak
Yavuz, Akif Selim
Turan, Esra
Yönal, İpek
Atay, Hilmi
Keltikli, Engin
Turgut, Mehmet
Pehlivan, Mustafa
Akay, Meltem Olga
Gürkan, Emel
Paydaş, Semra
Kahraman, Selda
Demirkan, Fatih
Kırkızlar, Onur
Akpınar, Seval
Pamuk, Gülsüm Emel
Demir, Muzaffer
Özbaş, Hasan Mücahit
Sönmez, Mehmet
Gültürk, Mine
Salihoğlu, Ayşe
Eşkazan, Ahmet Emre
Ar, Cem
Haydaroğlu Şahin, Handan
Öngören, Şeniz
Başlar, Zafer
Aydın, Yıldız
Yenere, Mustafa Nuri
Tüzüner, Nükhet
Ferhanoğlu, Burhan
Haznedaroglu, İbrahim C.
İlhan, Osman
Soysal, Teoman
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: here have been tremendous changes in treatment and follow-up of patients with chronic myeloid leukemia (CML) in the last decade. Especially, regular publication and updating of NCCN and ELN guidelines have provided enermous rationale and base for close monitorization of patients with CML. But, it is stil needed to have registry results retrospectively to evaluate daily CML practices. , Materials and Methods: In this article, we have evaluated 1133 patients’ results with CML in terms of demographical features, disease status, response, resistance and use of second-generation TKIs. , Results: The response rate has been found relatively high in comparison with previously published articles, and we detected that there was a lack of appropriate and adequate molecular response assessment. , Conclusion: We concluded that we need to improve registry systems and increase the availability of molecular response assessment to provide high-quality patient care., Conflict of interest:None declared.
Bağlantı
https://doi.org/10.4274/tjh.2013.0151https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874976/
http://hdl.handle.net/11655/15429